Victory Capital Management Inc. reduced its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 27.7% during the 3rd quarter, Holdings Channel.com reports. The firm owned 214,775 shares of the company’s stock after selling 82,461 shares during the period. Victory Capital Management Inc.’s holdings in Corteva were worth $14,525,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in CTVA. Activest Wealth Management lifted its stake in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares during the period. True Wealth Design LLC grew its position in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the period. Total Investment Management Inc. acquired a new position in Corteva during the second quarter worth about $27,000. Twin Peaks Wealth Advisors LLC purchased a new position in Corteva in the second quarter valued at about $29,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva during the 3rd quarter valued at approximately $29,000. 81.54% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Corteva
In related news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.15% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Read Our Latest Analysis on CTVA
Corteva Trading Down 2.6%
Shares of CTVA opened at $76.30 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The firm has a 50 day simple moving average of $73.40 and a 200-day simple moving average of $69.06. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90. The stock has a market cap of $51.31 billion, a price-to-earnings ratio of 48.29, a price-to-earnings-growth ratio of 2.68 and a beta of 0.72.
Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Recommended Stories
- Five stocks we like better than Corteva
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
